Icahn School of Medicine at Mount Sinai
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Icahn School of Medicine at Mount Sinai sits in the top decile of US sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count).
Icahn School of Medicine at Mount Sinai: 708 sponsored US clinical trials, 163 recruiting.
Icahn School of Medicine at Mount Sinai sponsors 708 registered US clinical trials on ClinicalTrials.gov, 163 of them currently recruiting, and 423 completed. 88 of these trials are in Phase 3-4 (later-stage) and 138 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 7 trials.
Top-decile sponsor footprint
Icahn School of Medicine at Mount Sinai ranks in the top decile of sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
423 of 499 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
708 total, page 3 of 15
Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
NCT06288282
Changes in Inhibition and Valuation After Eating
NCT05995496
Persuasive Health Communication Intervention for HIV/HCV
NCT05968573
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
NCT06945315
Maternal And Infant Antipsychotic Study
NCT06049953
CTSN Embolic Protection Trial
NCT06027788
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients
NCT05016219
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
NCT06001450
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
NCT05835466
Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis
NCT05968560
Community-based Implementation of Online EmReg
NCT05933629
Network Neurofeedback Using 7-Tesla MRI to Reduce Rumination Levels in Depression
NCT05933148
The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection
NCT05652088
Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE
NCT05873218
Pembrolizumab for Advanced NSCLC and PS 2-3
NCT05589818
Development and Testing of a Peer-Coaching Model for the Treatment of Eating Disorders
NCT05562258
Delivering Empowering Conversations About Obstetric Regional Anesthesia for Underserved Minorities
NCT05260242
Imaging Coronary Microvascular Dysfunction (CMD) Study
NCT05634031
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials
NCT05146297
Neurocognitive and Genomic Predictors of Persistent Pain and Opioid Misuse After Spine Surgery
NCT06288256
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
NCT05462496
Interoceptive Exposure for Adolescents With Low Weight Eating Disorders
NCT05763849
Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma
NCT05188118
The Ambient Light Multiple Myeloma Study
NCT05737732
Vancomycin Study in Multiple Sclerosis (MS)
NCT05539729
DevRobust Treatment for Mal de Débarquement Syndrome
NCT05460520
Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders
NCT05554172
Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study
NCT05675332
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
NCT05197309
A Multi Center Study of Sexual Toxicities After Radiotherapy
NCT05394428
Identification of Acute Intermittent Porphyria Modifying Genes
NCT05502133
Transcranial Ultrasound Via Sonolucent Cranioplasty After Minimally Invasive Intracerebral Hemorrhage Evacuation
NCT05538286
The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
NCT05419089
Intraventricular Catheter System for IVH
NCT05970549
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
NCT05982925
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
NCT05223192
Screening Women With Prior HPV for Anal Neoplasia
NCT05217940
Environmental Factors and Thyroid Cancer
NCT05172921
TSCS for Acute SCI
NCT05305118
Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients
NCT05239780
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
NCT04983875
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
NCT05095207
Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder
NCT05160129
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
NCT04615988
Early Feeding After Oral Cavity Reconstruction
NCT04787939
Biologics And Clinical Immunology Cohort at Sinai
NCT04784364
Use of ReDS Technology in Patients With Acute Heart Failure
NCT04305717
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
NCT04353778
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
NCT04045665
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
NCT04199000
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 57 |
| Phase 2 | 81 |
| Phase 3 | 21 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Icahn School of Medicine at Mount Sinai pipeline
163 recruiting of 708 indexed (23% open); 423 completed (60%).
Phase mix: 88 late (III/IV) vs 138 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Icahn School of Medicine at Mount Sinai: open-pipeline peers nationwide
Peers matched on 708 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Icahn School of Medicine at Mount Sinai sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 708 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
- University of Miami · 721 trials · 20% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
- Rahul Aggarwal · 23% recruiting · 13 trials
- Sequenom · 23% recruiting · 26 trials
Related
What to do with this Icahn School of Medicine at Mount Sinai page
708 registered trials is a research-attention snapshot, not an endorsement of Icahn School of Medicine at Mount Sinai or any single study.
- 163 of Icahn School of Medicine at Mount Sinai's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Icahn School of Medicine at Mount Sinai studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Icahn School of Medicine at Mount Sinai pipeline card: 708 registered trials from official public datasets.Report a data error.